Variation In Genes Required For Normal Mitosis And Risk Of Breast Cancer

gan Olson, JE, Wang, X, Goode, EL, Pankratz, VS, Fredericksen, ZS, Vierkant, RA, Pharoah, P, Cerhan, JR, Couch, FJ
Cyhoeddwyd 2009

Biobanks and personalized medicine

gan Olson, J.E., Bielinski, S.J., Ryu, E., Winkler, E.M., Takahashi, P.Y., Pathak, J., Cerhan, J.R.
Cyhoeddwyd yn Clin Genet (2014)

Residential Proximity to Industrial Facilities and Risk of Non-Hodgkin Lymphoma

gan De Roos, AJ, Davis, S, Colt, JS, Blair, A, Airola, M, Severson, RK, Cozen, W, Cerhan, JR, Hartge, P, Nuckols, JR, Ward, MH
Cyhoeddwyd 2010

The Functional Assessment of Cancer Therapy – General (FACT-G) is valid for monitoring quality of life in non-Hodgkin lymphoma patients

gan Yost, KJ, Thompson, CA, Eton, DT, Allmer, C, Ehlers, SL, Habermann, TM, Shanafelt, TD, Maurer, MJ, Slager, SL, Link, BK, Cerhan, JR
Cyhoeddwyd 2012

Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma

gan Abdou, AM, Gao, X, Cozen, W, Cerhan, JR, Rothman, N, Martin, MP, Davis, S, Schenk, M, Chanock, SJ, Hartge, P, Carrington, M, Wang, SS
Cyhoeddwyd yn Leukemia (2010)

Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS

gan Katzmann, JA, Clark, R, Kyle, RA, Larson, DR, Therneau, TM, Melton, LJ, Benson, JT, Colby, CL, Dispenzieri, A, Landgren, O, Kumar, S, Bradwell, AR, Cerhan, JR, Rajkumar, SV
Cyhoeddwyd 2012

Event-Free Survival at 24 Months Captures Central Nervous System Relapse of Systemic Diffuse Large B-cell Lymphoma in the Immunochemotherapy Era

gan Thanarajasingam, G, Maurer, MJ, Farooq, U, Johnston, PB, Thompson, CA, Bennani, NN, Ansell, SM, Porrata, LF, Macon, WR, Syrbu, SI, Cerhan, JR, Habermann, TM, Link, BK, Witzig, TE, Nowakowski, GS
Cyhoeddwyd yn Br J Haematol (2017)

Widespread Use of Complementary and Alternative Medicine (CAM) among Non-Hodgkin Lymphoma (NHL) Survivors

gan Osian, S. Rausch, Leal, A.D., Allmer, C., Maurer, M.J., Nowakowski, G., Inwards, D.J., Macon, W.R., Ehlers, S.L., Weiner, G.J., Habermann, T.M., Cerhan, J.R., Thompson, C.A.
Cyhoeddwyd yn Leuk Lymphoma (2014)

Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma

gan Hu, G, Dasari, S, Asmann, YW, Greipp, PT, Knudson, RA, Benson, HK, Li, Y, Eckloff, BW, Jen, Jin, Link, BK, Jiang, L, Sidhu, JS, Wellik, LE, Witzig, TE, Bennani, NN, Cerhan, JR, Boddicker, RL, Feldman, AL
Cyhoeddwyd yn Leukemia (2017)

Pilot Study: Association of Traditional and Genetic Risk Factors and New-Onset Diabetes Mellitus Following Kidney Transplantation

gan Chakkera, H.A., Hanson, R.L., Raza, S.M., DiStefano, J.K., Millis, M.P., Heilman, R.L., Mulligan, D.C., Reddy, K.S., Mazur, M.J., Hamawi, K., Moss, A.A., Mekeel, K.L., Cerhan, J.R.
Cyhoeddwyd 2009

A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus

gan Cozen, W, Timofeeva, MN, Li, D, Diepstra, A, Hazelett, D, Delahaye-Sourdeix, M, Edlund, CK, Franke, L, Rostgaard, K, Van Den Berg, DJ, Cortessis, VK, Smedby, KE, Glaser, SL, H-J, Westra, Robison, LL, Mack, TM, Ghesquieres, H, Hwang, AE, Nieters, A, de Sanjose, S, Lightfoot, T, Becker, N, Maynadie, M, Foretova, L, Roman, E, Benavente, Y, Rand, KA, Nathwani, BN, Glimelius, B, Staines, A, Boffetta, P, Link, BK, Kiemeney, L, Ansell, SM, Bhatia, S, Strong, LC, Galan, P, Vatten, L, Habermann, TM, Duell, EJ, Lake, A, Veenstra, RN, Visser, L, Liu, Y, Urayama, KY, Montgomery, D, Gaborieau, V, Weiss, LM, Byrnes, G, Lathrop, M, Cocco, P, Best, T, Skol, AD, H-O, Adami, Melbye, M, Cerhan, JR, Gallagher, A, Taylor, GM, Slager, SL, Brennan, P, Coetzee, GA, Conti, DV, Onel, K, Jarrett, RF, Hjalgrim, H, van den Berg, A, McKay, JD
Cyhoeddwyd 2014